Maxime Dely: The Lifesaving Power of Plasma Donations
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:
”Plasma matters more than we think.
With this 3rd donation of the year, the goal of 10 donations in 2026 remains well on track.
Beyond the gesture itself, each donation helps collect valuable components used every day in medicine.
Among them, fibrinogen plays a central role: this protein is directly involved in blood clotting, transforming into fibrin, which is essential for forming the clot that helps stop bleeding.
Without sufficient fibrinogen, certain medical procedures become far more complex, especially in cases of surgery, trauma, or specific coagulation disorders.
Donating plasma means contributing directly to an essential care chain — often invisible, yet vital for many patients.
A simple, regular, and meaningful contribution.”
Stay updated with Hemostasis Today.
-
Mar 20, 2026, 16:31Jerome Winegarden: ASH Continues to Show Exceptional Leadership by Advocating for Patients With Blood Diseases
-
Mar 20, 2026, 16:28Breanna Beers: A Remarkable Case of ‘Generation Skipping’ Marfan Syndrome
-
Mar 20, 2026, 16:26Results from The HUNT Study on The Role of Plasma miR-145-5p Levels in Cancer-Associated VTE – JTH
-
Mar 20, 2026, 16:23Eva Soler Espejo։ Atherogenic Index of Plasma and Residual Risk in Atrial Fibrillation
-
Mar 20, 2026, 16:22Welcoming Samer Al Hadidi to the Blood Cancers Team – UT Southwestern Simmons Cancer Center
-
Mar 20, 2026, 16:20Yves Bikorimana: Hemolysis – Why It Ruins Laboratory Results
-
Mar 20, 2026, 16:19Simon Senanu: G6PD Deficiency Testing – What the Lab Must Get Right
-
Mar 20, 2026, 16:18Khaled Elshazly: Can We Stop Chemotherapy-Induced Thrombocytopenia from Delaying Treatment?
-
Mar 20, 2026, 15:50Rithwic Mani: Platelet-to-Lymphocyte Ratio as A Simple and Cost-Effective Prognostic Biomarker in Stroke